NCI

Value Q4, 24 TTM Total revenue — — Gross profit — — Operating expenses 190.76 K — Selling/general/admin expenses — — Research & development — — Operating income -190.76 K — Non-Operating Income, Total — — Interest expense, net of interest capitalized — — Non-Operating Income, excl. Interest Expenses — — Unusual income/expense — — Pretax income -190.76 K — Equity in earnings — — Taxes — — Non-controlling/minority interest — — After tax other income/expense — — Net income before discontinued operations -190.76 K — Discontinued operations — — Net income -190.76 K — Dilution adjustment — — Preferred dividends — — Diluted net income available to common stockholders -190.76 K — Basic earnings per share (Basic EPS) 0.05 — Diluted earnings per share (Diluted EPS) 0.05 — Average basic shares outstanding 3.92 M — Diluted shares outstanding 3.92 M — EBITDA — — EBIT — — Cost of revenue — — Other cost of goods sold — — Depreciation & amortization (cash flow) 190.76 K —